Skip to content
Austin Top 50
Author:
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 2, 2026
Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies
March 31, 2026
←
Previous Page
1
2